3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
20
Lymphoma
6
Lymphoma, T-Cell, Peripheral
5
Lymphoma, T-Cell
5
Mycosis Fungoides
4
Lymphoma, T-Cell, Cutaneous
4
Lymphomatoid Papulosis
3
Lymphoma, Large-Cell, Anaplastic
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Lymphoma, Primary Cutaneous Anaplastic Large Cell
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Immunoblastic Lymphadenopathy
2
Hematologic Diseases
2
Enteropathy-Associated T-Cell Lymphoma
2
Squamous Cell Carcinoma of Head and Neck
1
Sezary Syndrome
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Mesothelioma, Malignant
1
Melanoma
1
Lymphoma, Extranodal NK-T-Cell
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Large Granular Lymphocytic
1
Leukemia
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Etoposide
2
Carboplatin
2
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
Thiotepa
1
Standard of Care
1
Second-Look Surgery
1
Respiratory Physiological Phenomena
1
Reoperation
1
Radiotherapy
1
Radiation
1
Practice Guidelines as Topic
1
Platinum
1
Peripheral Blood Stem Cell Transplantation
1
Mesna
1
Ifosfamide
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Cisplatin
1
Bleomycin
1
Biopsy
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Embryonal
×
Brentuximab Vedotin
×
1 year
×
Clear all
No trials found.